APAC Viscosupplementation Market - Industry Trends and Forecast to 2029

APAC Viscosupplementation Market - Industry Trends and Forecast to 2029

Asia-Pacific viscosupplementation market is projected to register a substantial CAGR of 9.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.

Market Segmentation

Asia-Pacific Viscosupplementation Market, By Source (animal origin and non-animal origin), Age Group (geriatric and adults), Injection (single injection, three injections, and five injections), Molecular Weight (intermediate molecular weight, low molecular weight, and high molecular weight), End User (hospital, orthopedic clinics, ambulatory care centers, and others), Distribution Channel (direct tender and retail sales), Country(China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific viscosupplementation market are:
Rising geriatric population
Increasing risk of osteoporosis and osteoarthritis

Market Segmentation

Asia-Pacific viscosupplementation market is categorized into six notable segments, which are the source, age group, molecular weight, injection, end user, and distribution channel.
On the basis of source, the Asia Pacific viscosupplementation market is segmented into animal origin and non-animal origin
On the basis of molecular weight, the Asia Pacific viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight
On the basis of injection, the Asia Pacific viscosupplementation market is segmented into single injection, three injections, and five injections
On the basis of age group, the Asia Pacific viscosupplementation market is segmented into geriatric and adults
On the basis of end-user, the Asia Pacific viscosupplementation market is segmented into hospitals, orthopedic clinics, ambulatory care centers, and others
On the basis of distribution channel, the Asia Pacific viscosupplementation market is segmented into direct tender and retail sales

Market Players

The key market players operating in the Asia-Pacific viscosupplementation market are listed below:


Anika Therapeutics, Inc.
SEIKAGAKU CORPORATION
Bioventus
Fidia Farmaceutici S.P.A
Ferring B.V
sanofi-aventis U.S. LLC
Zimmer Biomet

Company Profiles

Anika Therapeutics, Inc.
SEIKAGAKU CORPORATION
Bioventus
Fidia Farmaceutici S.P.A
Ferring B.V
sanofi-aventis U.S. LLC
Zimmer Biomet
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.